/Lists

Biotech Series A Investors & VC Firms

1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.

LYFE Capital
Menlo ParkSeed–Late Stage
22 people
AdBio partners
ParisSeed–Series A
21 people
Big Pi Ventures
AthensSeed–Growth$540K – $3.2M
16 people
Cantos Ventures
San FranciscoPre-Seed–Series B$400K – $1.5M
5 people
Catalys Pacific
TokyoSeed–Series A
26 people
Northstar Ventures
Newcastle upon TynePre-Seed–Late Stage$38.1K – $1.3M
17 people
DCVC Bio
Palo AltoSeed–Growth
14 people
Forepont Capital Partners
New YorkPre-Seed–Series A
24 people
ScaleX Ventures
AmsterdamSeed–Series A$216K – $2.2M
12 people
SpringTide Ventures
BostonSeed–Series B$500K – $5M
15 people
Sonder Capital
San CarlosPre-Seed–Series C
17 people
WRF Capital
SeattlePre-Seed–Series A$100K – $2M
20 people
GVFL Ltd.
AhmedabadPre-Seed–Series B$250K – $25M
22 people
Systemiq Capital
LondonSeries A
16 people
Cure Ventures
BostonPre-Seed–Series A
20 people
Delta Partners
DublinPre-Seed–Series A$108K – $3.2M
6 people
LVX Ventures
BangalorePre-Seed–Growth
1 person
Tullis Health Investors
Palm Beach GardensSeries A–Late Stage$500K – $10M
17 people
MoreVC
Ra'ananaPre-Seed–Series A$500K – $3.5M
6 people
LOUD Capital
ColumbusSeed–Growth
25 people
Phoenix Venture Partners
San MateoSeed–Series A$100K – $3M
10 people
DG Incubation
Seed–Series A
Dimension Capital
San FranciscoSeed–Growth$1M – $10M
16 people
Innospark Ventures
BostonPre-Seed–Series A$2M
12 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.